ArticleUpdates in DMTs and MS Economic Burden From ACTRIMS 2022 Author:Michael Wilson, MDPublish date: March 18, 2022Dr Michael Wilson reviews updates from ACTRIMS 2022 on DMTs, autologous stem cell transplant, long-term tolebrutinib results as evident on MRI, and...Read More